Navigation Links
Zansors Secures Issued Patent for Heart Monitoring Device
Date:5/16/2017

Zansors has secured a patent from U.S. Patent and Trademark Office (USPTO) for a wireless electrocardiogram (ECG or EKG) acquisition and monitoring device. This Zansors’ next-generation intellectual property (IP), will allow heart- monitoring devices to be integrated into clothing, or secured directly onto the skin, making them significantly easier to deploy and use.

Currently, ECG sensors use old-standard technology that requires electrodes to be in contact with the wearer’s skin. Zansors’ new patented device uses capacitive sensors, a well-proven technology similar to the sensors found in cell phones and tablets. These sensors can measure electrical potentials without touching the body.

Zansors is opening up a future that allows patients the same accuracy of readings on their mobile device that they currently can only experience in a clinical setting.

“Zansors’ wearable health tech is going to change how you ‘know yourself,’ but we keep a focus on fact that the user has to have a great experience using the technology,” said Nicole Stout, DPT, Vice President of Medical Affairs at Zansors. “Focusing on a patient-friendly experience with wearables has led directly to this patent.”

According to the January 2017 American Heart Association Heart Disease and Stroke Statistics Update, the number of people diagnosed with heart failure is increasing and projected to rise by 46 percent by 2030, resulting in more than 8 million people with heart failure.

ECGs monitor the heart’s electrical activity and can point to the cause of symptoms of heart disease. Zansors’ new patent will lead to monitoring capability in the hands of consumers who are at-risk for a cardiac episode. People will be able to share their ongoing results with their primary care doctor or cardiologist on a continuous basis, instead of at doctor’s visits. New medications or pacemakers that may affect the heart would be closely monitored to ensure they are effective.

“At Zansors, we have assembled a team of medical researchers, biostatisticians and clinicians to develop unique technologies to support accurate and usable health technology,” said Abhijit Dasgupta, Ph.D., Co-Founder and Chief Data Science Officer at Zansors. “This intellectual property granted by USPTO proves that we are doing that effectively.”

Global law firm DLA Piper’s Reston, Virginia location supported patent prosecution. For more information on this patent, view the summary. Learn more about Zansors’ technologies at http://www.zansors.com, where you can sign up for email updates, and follow us on Facebook and Twitter.

About Zansors

Zansors is a Washington, DC metro-based healthcare innovation company delivering Personal Healthcare Analytics into the hands of consumers via wearable bio-sensors and health apps. Driven by our credo of “know yourself,” Zansors combines evidence-based apps, bioengineering and data analytics, allowing consumers to take charge of their health. Our proprietary biotechnology platform includes micro-sensors and micro-fluidics (also known as “lab-on-a-chip”) backed by a strong portfolio of patents filed. Zansors has previously received 6 funding awards by NIH and has formal partnerships with the University of Michigan and George Washington University.

Read the full story at http://www.prweb.com/releases/2017/05/prweb14336164.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Zansors Announces Issued Patent Protecting Adhesive for Wearable Health Sensors
2. Zansors Wins NIH Grant to Advance Wearable At-Home Affordable Sleep Apnea Detection
3. Dermata Therapeutics, LLC Closes a $5 Million Series 1a Financing and Secures a $5 Million Credit Facility with Silicon Valley Bank
4. Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas
5. Renova Therapeutics secures novel AAV vector license for use in metabolic and cardiovascular gene therapy development
6. Sorrento Therapeutics, Inc. Secures $75 Million Loan Facility
7. BerGenBio Secures NOK212 Million Capital Raise
8. Global Leader In Pharmaceutical Cannabinoid Production Secures $7 Million With Tuatara Capital Leading The Series A Round
9. Biocept Secures Agreement with Preferred Provider Organization Prime Health Services
10. CytRx Secures $40 Million Long-Term Loan Facility
11. Zai Lab Secures Over $100M Series B Financing from Leading Healthcare Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time ... US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. ... US2020. , US2020’s mission is to change the trajectory of STEM education in ...
Breaking Biology Technology:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):